Export 549 results:
Author [ Title(Desc)] Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E. Portacolone, Johnson, J. K., Covinsky, K. E., Halpern, J., and Rubinstein, R. L., The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone., J Alzheimers Dis, vol. 61, no. 4, pp. 1517-1529, 2018.
C. Boutoleau-Bretonnière, Pouclet-Courtemanche, H., Gillet, A., Bernard, A., Deruet, A. Laure, Gouraud, I., Mazoue, A., Lamy, E., Rocher, L., Kapogiannis, D., and Haj, M. El, The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis., J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
N. Soldevila-Domenech, Forcano, L., Boronat, A., Lorenzo, T., Piera, I., Puig-Pijoan, A., Mateus, J., Gómez, J. María Gon, Knezevic, I., Soteras, A., Fauria, K., Pizarro, N., Molinuevo, J. Luis, and de la Torre, R., Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 79, no. 3, pp. 1015-1021, 2021.
K. Steen Frederiksen, Gjerum, L., Waldemar, G., and Hasselbalch, S. Gregers, Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies., J Alzheimers Dis, vol. 61, no. 1, pp. 359-372, 2018.
T. A. Lansdell, Xu, H., Galligan, J. J., and Dorrance, A. M., Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice., J Alzheimers Dis, vol. 94, no. 4, pp. 1361-1375, 2023.
H. Florian, Meier, A., Gauthier, S., Lipschitz, S., Lin, Y., Tang, Q., Othman, A. A., Robieson, W. Z., and Gault, L. M., Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study., J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.
F. Fan, Liu, H., Shi, X., Ai, Y., Liu, Q., and Cheng, Y., The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review., J Alzheimers Dis, vol. 85, no. 3, pp. 1195-1204, 2022.
A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial., J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.
A. J García-Casal, Goñi-Imizcoz, M., M Perea-Bartolomé, V., Soto-Pérez, F., Smith, S. Jane, Calvo-Simal, S., and Franco-Martín, M., The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
C. Tuena, Mancuso, V., Stramba-Badiale, C., Pedroli, E., Stramba-Badiale, M., Riva, G., and Repetto, C., Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review., J Alzheimers Dis, vol. 79, no. 1, pp. 95-116, 2021.
J. M. Riphagen, van Egroo, M., and Jacobs, H. I. L., Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline., J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
X. Guo, Zhang, G., Peng, Q., Huang, L., Zhang, Z., and Zhang, Z., Emerging Roles of Meningeal Lymphatic Vessels in Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S355-S366, 2023.
A. Imai, Matsuoka, T., and Narumoto, J., Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus., J Alzheimers Dis, vol. 93, no. 2, pp. 521-532, 2023.
H. Hochstetler, Trzepacz, P. T., Wang, S., Yu, P., Case, M., Henley, D. B., Degenhardt, E., Leoutsakos, J. - M., and Lyketsos, C. G., Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline., J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
B. Ahlemeyer, Halupczok, S., Rodenberg-Frank, E., Valerius, K. - P., and Baumgart-Vogt, E., Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation., J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
D. Cutuli, Landolfo, E., Petrosini, L., and Gelfo, F., Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders., J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
L. Calderón-Garcidueñas, Torres-Jardón, R., Franco-Lira, M., Kulesza, R., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. Adriana, García-Alonso, G., García-Rojas, E., Mukherjee, P. S., and Delgado-Chávez, R., Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution., J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
J. Gräff, Rei, D., Guan, J. - S., Wang, W. - Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., Su, S. C., Samiei, A., Joseph, N., Haggarty, S. J., Delalle, I., and Tsai, L. - H., An epigenetic blockade of cognitive functions in the neurodegenerating brain., Nature, vol. 483, no. 7388, pp. 222-6, 2012.
P. Chatterjee, Roy, D., and Rathi, N., Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome., J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., and Zaman, S. H., Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome., J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
A. Suzuki, Shinozaki, J., Yazawa, S., Ueki, Y., Matsukawa, N., Shimohama, S., and Nagamine, T., Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function., J Alzheimers Dis, vol. 61, no. 4, pp. 1653-1665, 2018.
N. Samudra, Ranasinghe, K., Kirsch, H., Rankin, K., and Miller, B., Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps., J Alzheimers Dis, vol. 92, no. 1, pp. 13-27, 2023.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
M. T. White, Shaw, L. M., and Xie, S. X., Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.